Osobní účet
Osobní účet
Freeline Therapeutics
Biotechnology company focused on developing liver directed gene therapies for a range of diseases
Kapitalizace
$276
Rok založení
2015
Uzávěrka
8/20/2020
Ziskovost
-3.61%
O společnosti
Total Funding
$302.1M
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases. The Company has clinical programs in Hemophilia B and Fabry disease, as well as preclinical programs in Gaucher disease and Hemophilia A. Freeline is headquartered in the UK and has operations in Germany and the US.
Number of employees
101 - 250
Headquarters
Stevenage, Herefordshire, United Kingdom